LFVN, low risk entry at pullback.Lifevantage pulled back to around 14$. Low risk entry point. Price is consolidating some days here.
(+) great revenue increse due to new product launch in october
(+) product is in the weight loss industry..a natural variant to ozempic
(+) Except more revenue increase next quarter. Start from new product was mid October.
(-) Due to new product launch expect lower margin (marketing etc.)
Trade: Entry : ~14$
Stopp Loss: 12$
First exit: at least 50% > 20$
